KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash & Current Investments (2016 - 2025)

Novavax has reported Cash & Current Investments over the past 16 years, most recently at $735.1 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $735.1 million for Q4 2025, down 20.37% from a year ago — trailing twelve months through Dec 2025 was $735.1 million (down 20.37% YoY), and the annual figure for FY2025 was $735.1 million, down 20.37%.
  • Cash & Current Investments for Q4 2025 was $735.1 million at Novavax, down from $762.9 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for NVAX hit a ceiling of $2.1 billion in Q2 2021 and a floor of $10.3 million in Q2 2022.
  • Median Cash & Current Investments over the past 5 years was $590.4 million (2023), compared with a mean of $733.3 million.
  • Biggest five-year swings in Cash & Current Investments: crashed 99.5% in 2022 and later soared 5417.86% in 2023.
  • Novavax's Cash & Current Investments stood at $1.5 billion in 2021, then crashed by 99.32% to $10.3 million in 2022, then soared by 5417.86% to $568.5 million in 2023, then skyrocketed by 62.38% to $923.1 million in 2024, then decreased by 20.37% to $735.1 million in 2025.
  • The last three reported values for Cash & Current Investments were $735.1 million (Q4 2025), $762.9 million (Q3 2025), and $612.3 million (Q2 2025) per Business Quant data.